Elixinol Global Limited Annual Report 2020

Group Note 2020 $’000 2019 $’000 Assets Current assets Cash and cash equivalents 10 27,743 20,244 Trade and other receivables 11 1,191 1,536 Inventories 12 4,735 21,314 Income tax refund due 8 509 88 Prepayments, deposits and other 13 1,176 6,731 35,354 49,913 Assets of disposal groups classified as held for sale – 1,444 Total current assets 35,354 51,357 Non-current assets Investments accounted for using the equity method 14 2,316 8,403 Property, plant and equipment 15 2,471 12,685 Right-of-use assets 16 1,412 4,323 Intangibles 17 917 39,994 Deferred tax 8 – 4,307 Total non-current assets 7,116 69,712 Total assets 42,470 121,069 Liabilities Current liabilities Trade and other payables 18 2,795 2,992 Contract liabilities 19 89 157 Lease liabilities 21 920 989 Income tax 8 29 – Employee benefits 344 86 Accrued expenses 818 843 4,995 5,067 Liabilities directly associated with assets classified as held for sale – 944 Total current liabilities 4,995 6,011 Consolidated Statement of Financial Position as at 31 December 2020 F INANCI AL REPORT 38 Elixinol Global Limited | Annual Report 2020